Maipu Medicine (301033.SZ) released its performance for the first three quarters, with net profit attributable to shareholders of RMB 90.3998 million, a year-on-year increase of 19.18%.

Zhitong Finance APP News, Medprin (301033.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 294 million yuan, a year-on-year increase of 18.09%; net profit attributable to shareholders of the listed company was 90.3998 million yuan, a year-on-year increase of 19.18%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 86.6858 million yuan, a year-on-year increase of 19.09%; basic earnings per share were 1.35 yuan.